Tech Company Financing Transactions
Aerpio Pharmaceuticals Funding Round
Aerpio Pharmaceuticals, based in Cincinnati, secured $41.8 million from private investors.
Transaction Overview
Company Name
Announced On
3/31/2017
Transaction Type
Venture Equity
Amount
$41,835,597
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 264 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9987 Carver Rd. 420
Cincinnati, OH 45242
USA
Cincinnati, OH 45242
USA
Phone
Website
Email Address
Overview
Aerpio Pharmaceuticals, a biopharmaceutical company,develops first-in-class treatments for ocular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Hoffman
Chief Financial Officer
Michael Rogers
Chief Medical Officer
Steve Pakola
Chief Scientific Officer
Kevin Peters
President
Joseph Gardner
Vice President
Brandi Soldo
VP - Bus. Development
Mitchell Brigell
VP - Finance
Gina Marek
Browse more venture capital transactions:
Prev: 3/31/2017: Zenjob venture capital transaction
Next: 3/31/2017: Filament venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs